[1]
“PHARMACOLOGICAL AND CLINICAL PROFILE OF REBAMIPIDE: NEW THERAPEUTIC TARGETS”, ijms, vol. 4, no. 12, pp. 444–446, Dec. 2024, doi: 10.55640/.